RemeGen Co., Ltd. (REGMF)
USD 1.5
(-26.47%)
USD 1.5
(-26.47%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.32 Billion CNY | 49.84% |
| 2022 | 1.55 Billion CNY | 47.29% |
| 2021 | 1.05 Billion CNY | 65.35% |
| 2020 | 637.24 Million CNY | 65.07% |
| 2019 | 386.04 Million CNY | 65.07% |
| 2018 | 233.85 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 83.05 Million USD | -100.0% |
| 2024 Q3 | 93.7 Million USD | -8.65% |
| 2024 Q2 | 97.62 Million USD | 0.0% |
| 2023 Q3 | 587.28 Million CNY | 661.34% |
| 2023 Q1 | 64.62 Million USD | -85.53% |
| 2023 FY | 2.32 Billion CNY | 49.84% |
| 2023 Q4 | 97.89 Million USD | -83.33% |
| 2023 Q2 | 77.13 Million USD | 19.36% |
| 2022 Q3 | 398.85 Million CNY | 703.26% |
| 2022 Q2 | 49.65 Million USD | -0.57% |
| 2022 Q1 | 49.94 Million USD | 71.53% |
| 2022 FY | 1.55 Billion CNY | 47.29% |
| 2022 Q4 | 446.51 Million CNY | 11.95% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 1.05 Billion CNY | 65.35% |
| 2021 Q4 | 29.11 Million USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2020 FY | 637.24 Million CNY | 65.07% |
| 2020 Q4 | 22.55 Million USD | 0.0% |
| 2019 FY | 386.04 Million CNY | 65.07% |
| 2018 FY | 233.85 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 10.86 Million USD | -21298.178% |
| Skye Bioscience, Inc. | 13.54 Million USD | -17064.284% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | -6141.573% |
| Nascent Biotech, Inc. | 2.22 Million USD | -104180.995% |
| Qrons Inc. | 643.67 Thousand USD | -361158.83% |
| Adynxx, Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 22.97 Million USD | -10021.262% |
| CSL Limited | 3.44 Billion USD | 32.579% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -7768.372% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -46018.995% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -251693.7% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | -3948.294% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -559576.903% |
| Rebus Holdings, Inc. | 664 Thousand USD | -350101.807% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -174026.555% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -596805.274% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -14424.082% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | -2579.426% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -47183.065% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -888363.508% |
| SQZ Biotechnologies Company | 85.61 Million USD | -2615.916% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -79637.744% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -154726.656% |
| Mesoblast Limited | 5.9 Million USD | -39299.187% |
| Marizyme, Inc. | 19.23 Million USD | -11986.072% |
| Genus plc | 147.7 Million USD | -1474.367% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -26386.821% |
| Pharming Group N.V. | 225.49 Million USD | -931.234% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -113402.92% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -173232.985% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -27785.118% |
| ContraFect Corporation | 56.88 Million USD | -3987.504% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -52644.681% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -157150.168% |
| IMV Inc. | 37.7 Million USD | -6066.503% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -83234.856% |
| MultiCell Technologies, Inc. | 567.42 USD | -409809212.326% |
| ONE Bio Corp. | 6.44 Million USD | -35985.956% |
| Accustem Sciences Inc. | 3.74 Million USD | -61968.338% |
| RVL Pharmaceuticals plc | 85.94 Million USD | -2605.614% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -437025.208% |
| Q BioMed Inc. | 3.43 Million USD | -67563.419% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -9308.618% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -88399.354% |
| Biomind Labs Inc. | 994.18 Thousand USD | -233794.8% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | -2241.021% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -132045.768% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -34513.498% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -124625.242% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 9301460.0% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -126614.966% |
| GB Sciences, Inc. | 1.42 Million USD | -163597.66% |
| Alpha Cognition Inc. | 9.7 Million USD | -23858.743% |
| HST Global, Inc. | 140.9 Thousand USD | -1650165.778% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -206613.426% |
| Halberd Corporation | 74.84 Thousand USD | -3106898.744% |
| Enzolytics Inc. | 2.17 Million USD | -106591.1% |
| Agentix Corp. | 1.37 Million USD | -169415.57% |
| Resverlogix Corp. | 12.71 Million USD | -18192.48% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -63595.607% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | -51.633% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -222633.716% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -96590.387% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -147133.523% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -68192.345% |
| AVAX Technologies, Inc. | 7.31 Million USD | -31709.248% |
| Zenith Capital Corp. | 8.94 Million USD | -25901.789% |
| Genscript Biotech Corporation | 825.34 Million USD | -181.742% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -13347813.438% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -94606.305% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -1355712.231% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -120954.336% |
| Kadimastem Ltd | 2.41 Million USD | -96382.653% |
| Helix BioMedix, Inc. | 1.97 Million USD | -117815.817% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -1281184.955% |
| LadRx Corporation | 3.81 Million USD | -60903.869% |
| Cell Source, Inc. | 4.32 Million USD | -53660.786% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -251693.7% |
| NovAccess Global Inc. | 2.46 Million USD | -94166.935% |
| Affymax, Inc. | 39.38 Million USD | -5803.976% |
| Itoco Inc. | 919.14 Thousand USD | -252890.014% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -54763.447% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -207705.183% |
| Mobile Lads Corp. | 554.54 Thousand USD | -419223.194% |
| CytoDyn Inc. | 18.05 Million USD | -12777.063% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -9238805.002% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -1056498.115% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -163680.328% |
| SYBLEU INC | 160.87 Thousand USD | -1445323.805% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -127924.797% |
| International Stem Cell Corporation | 5.27 Million USD | -44015.728% |
| Bioxytran, Inc. | 3.82 Million USD | -60770.432% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -4417171.38% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -11430564.111% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | -6311.901% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -143616.934% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -315913.78% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -74645.741% |
| Neutra Corp. | 243.82 Thousand USD | -953607.843% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -13220.387% |
| PureTech Health plc | 144.59 Million USD | -1508.152% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -11248.72% |
| IXICO plc | 4.7 Million USD | -49301.742% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -26333.33% |
| Gelesis Holdings, Inc. | 117.74 Million USD | -1874.845% |
| CSL Limited | 3.89 Billion USD | 40.269% |
| Cellectis S.A. | 97.32 Million USD | -2289.375% |